nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CYP2C9—Thalidomide—leprosy	0.189	0.263	CbGbCtD
Dorzolamide—CYP2C9—Rifampicin—leprosy	0.183	0.255	CbGbCtD
Dorzolamide—CYP2C9—Dapsone—leprosy	0.151	0.211	CbGbCtD
Dorzolamide—CYP3A4—Rifampicin—leprosy	0.106	0.148	CbGbCtD
Dorzolamide—CYP3A4—Dapsone—leprosy	0.0877	0.122	CbGbCtD
Dorzolamide—CA6—ear—leprosy	0.0157	0.299	CbGeAlD
Dorzolamide—Arterial thrombosis—Thalidomide—leprosy	0.0126	0.0543	CcSEcCtD
Dorzolamide—Rales—Thalidomide—leprosy	0.00825	0.0356	CcSEcCtD
Dorzolamide—Cerebral ischaemia—Thalidomide—leprosy	0.007	0.0303	CcSEcCtD
Dorzolamide—Psoriasis—Thalidomide—leprosy	0.00539	0.0233	CcSEcCtD
Dorzolamide—CA1—nerve—leprosy	0.00526	0.0999	CbGeAlD
Dorzolamide—Hepatomegaly—Thalidomide—leprosy	0.00478	0.0207	CcSEcCtD
Dorzolamide—Influenza—Dapsone—leprosy	0.00415	0.0179	CcSEcCtD
Dorzolamide—CA4—nerve—leprosy	0.00411	0.0781	CbGeAlD
Dorzolamide—Vasodilation procedure—Thalidomide—leprosy	0.00385	0.0166	CcSEcCtD
Dorzolamide—Vasodilation—Thalidomide—leprosy	0.00385	0.0166	CcSEcCtD
Dorzolamide—Atrioventricular block—Thalidomide—leprosy	0.00349	0.0151	CcSEcCtD
Dorzolamide—Sinusitis—Dapsone—leprosy	0.00347	0.015	CcSEcCtD
Dorzolamide—Pharyngitis—Dapsone—leprosy	0.0033	0.0142	CcSEcCtD
Dorzolamide—Blood urea increased—Thalidomide—leprosy	0.0032	0.0138	CcSEcCtD
Dorzolamide—Dry eye—Thalidomide—leprosy	0.00313	0.0135	CcSEcCtD
Dorzolamide—Tinnitus—Dapsone—leprosy	0.0031	0.0134	CcSEcCtD
Dorzolamide—Pulmonary oedema—Thalidomide—leprosy	0.00301	0.013	CcSEcCtD
Dorzolamide—Erythema—Dapsone—leprosy	0.00289	0.0125	CcSEcCtD
Dorzolamide—CA12—eye—leprosy	0.00277	0.0527	CbGeAlD
Dorzolamide—Vision blurred—Dapsone—leprosy	0.00272	0.0118	CcSEcCtD
Dorzolamide—Eye pain—Thalidomide—leprosy	0.00272	0.0118	CcSEcCtD
Dorzolamide—Cardiac failure congestive—Thalidomide—leprosy	0.00271	0.0117	CcSEcCtD
Dorzolamide—Libido decreased—Thalidomide—leprosy	0.00265	0.0114	CcSEcCtD
Dorzolamide—Amnesia—Thalidomide—leprosy	0.00262	0.0113	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Thalidomide—leprosy	0.0026	0.0112	CcSEcCtD
Dorzolamide—Vertigo—Dapsone—leprosy	0.0026	0.0112	CcSEcCtD
Dorzolamide—Visual disturbance—Thalidomide—leprosy	0.00259	0.0112	CcSEcCtD
Dorzolamide—Cough—Dapsone—leprosy	0.00252	0.0109	CcSEcCtD
Dorzolamide—Hypoglycaemia—Thalidomide—leprosy	0.00252	0.0109	CcSEcCtD
Dorzolamide—Cardiac failure—Thalidomide—leprosy	0.00252	0.0109	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Thalidomide—leprosy	0.00251	0.0108	CcSEcCtD
Dorzolamide—CA9—tendon—leprosy	0.00248	0.0472	CbGeAlD
Dorzolamide—Pain in extremity—Thalidomide—leprosy	0.00246	0.0106	CcSEcCtD
Dorzolamide—Diplopia—Thalidomide—leprosy	0.00246	0.0106	CcSEcCtD
Dorzolamide—Disturbance in sexual arousal—Thalidomide—leprosy	0.00244	0.0105	CcSEcCtD
Dorzolamide—Affect lability—Thalidomide—leprosy	0.00242	0.0104	CcSEcCtD
Dorzolamide—CA14—tendon—leprosy	0.00236	0.0448	CbGeAlD
Dorzolamide—Cardiac arrest—Thalidomide—leprosy	0.00234	0.0101	CcSEcCtD
Dorzolamide—Mood swings—Thalidomide—leprosy	0.00233	0.0101	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00221	0.00956	CcSEcCtD
Dorzolamide—CA1—eye—leprosy	0.0022	0.0418	CbGeAlD
Dorzolamide—Insomnia—Dapsone—leprosy	0.00213	0.00922	CcSEcCtD
Dorzolamide—Influenza—Thalidomide—leprosy	0.00212	0.00917	CcSEcCtD
Dorzolamide—Bronchospasm—Thalidomide—leprosy	0.00209	0.00902	CcSEcCtD
Dorzolamide—Angina pectoris—Thalidomide—leprosy	0.00207	0.00894	CcSEcCtD
Dorzolamide—CA9—testis—leprosy	0.00206	0.0391	CbGeAlD
Dorzolamide—Bronchitis—Thalidomide—leprosy	0.00204	0.00882	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Thalidomide—leprosy	0.00197	0.00853	CcSEcCtD
Dorzolamide—Erectile dysfunction—Thalidomide—leprosy	0.00196	0.00845	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Dapsone—leprosy	0.00193	0.00833	CcSEcCtD
Dorzolamide—Weight decreased—Thalidomide—leprosy	0.00192	0.0083	CcSEcCtD
Dorzolamide—Hyperglycaemia—Thalidomide—leprosy	0.00192	0.00828	CcSEcCtD
Dorzolamide—Depression—Thalidomide—leprosy	0.00189	0.00816	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00188	0.00811	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Thalidomide—leprosy	0.00187	0.00806	CcSEcCtD
Dorzolamide—Abdominal pain—Dapsone—leprosy	0.00186	0.00806	CcSEcCtD
Dorzolamide—Body temperature increased—Dapsone—leprosy	0.00186	0.00806	CcSEcCtD
Dorzolamide—Myocardial infarction—Thalidomide—leprosy	0.00186	0.00802	CcSEcCtD
Dorzolamide—Conjunctivitis—Thalidomide—leprosy	0.00184	0.00795	CcSEcCtD
Dorzolamide—Sweating—Thalidomide—leprosy	0.00182	0.00784	CcSEcCtD
Dorzolamide—Epistaxis—Thalidomide—leprosy	0.00179	0.00772	CcSEcCtD
Dorzolamide—Sinusitis—Thalidomide—leprosy	0.00178	0.00767	CcSEcCtD
Dorzolamide—Agranulocytosis—Thalidomide—leprosy	0.00177	0.00763	CcSEcCtD
Dorzolamide—Bradycardia—Thalidomide—leprosy	0.00173	0.00748	CcSEcCtD
Dorzolamide—Pharyngitis—Thalidomide—leprosy	0.00169	0.00729	CcSEcCtD
Dorzolamide—CA5B—tendon—leprosy	0.00165	0.0313	CbGeAlD
Dorzolamide—Visual impairment—Thalidomide—leprosy	0.00164	0.00708	CcSEcCtD
Dorzolamide—Erythema multiforme—Thalidomide—leprosy	0.00161	0.00694	CcSEcCtD
Dorzolamide—Tinnitus—Thalidomide—leprosy	0.00158	0.00685	CcSEcCtD
Dorzolamide—Arrhythmia—Thalidomide—leprosy	0.00152	0.00656	CcSEcCtD
Dorzolamide—Alopecia—Thalidomide—leprosy	0.0015	0.00649	CcSEcCtD
Dorzolamide—Vomiting—Dapsone—leprosy	0.0015	0.00648	CcSEcCtD
Dorzolamide—CA12—nervous system—leprosy	0.00149	0.0284	CbGeAlD
Dorzolamide—Headache—Dapsone—leprosy	0.00148	0.00638	CcSEcCtD
Dorzolamide—Tension—Thalidomide—leprosy	0.00145	0.00627	CcSEcCtD
Dorzolamide—Dysgeusia—Thalidomide—leprosy	0.00145	0.00626	CcSEcCtD
Dorzolamide—Nervousness—Thalidomide—leprosy	0.00144	0.00621	CcSEcCtD
Dorzolamide—Back pain—Thalidomide—leprosy	0.00143	0.00618	CcSEcCtD
Dorzolamide—CA2—eye—leprosy	0.00142	0.0271	CbGeAlD
Dorzolamide—Nausea—Dapsone—leprosy	0.0014	0.00605	CcSEcCtD
Dorzolamide—Vision blurred—Thalidomide—leprosy	0.00139	0.00602	CcSEcCtD
Dorzolamide—CA5B—testis—leprosy	0.00136	0.0259	CbGeAlD
Dorzolamide—Angioedema—Thalidomide—leprosy	0.00135	0.00584	CcSEcCtD
Dorzolamide—CA5B—nervous system—leprosy	0.00134	0.0254	CbGeAlD
Dorzolamide—Vertigo—Thalidomide—leprosy	0.00133	0.00574	CcSEcCtD
Dorzolamide—Syncope—Thalidomide—leprosy	0.00133	0.00573	CcSEcCtD
Dorzolamide—Palpitations—Thalidomide—leprosy	0.00131	0.00565	CcSEcCtD
Dorzolamide—Loss of consciousness—Thalidomide—leprosy	0.0013	0.00562	CcSEcCtD
Dorzolamide—Cough—Thalidomide—leprosy	0.00129	0.00558	CcSEcCtD
Dorzolamide—Hypertension—Thalidomide—leprosy	0.00128	0.00552	CcSEcCtD
Dorzolamide—Arthralgia—Thalidomide—leprosy	0.00126	0.00544	CcSEcCtD
Dorzolamide—Chest pain—Thalidomide—leprosy	0.00126	0.00544	CcSEcCtD
Dorzolamide—Anxiety—Thalidomide—leprosy	0.00126	0.00542	CcSEcCtD
Dorzolamide—Discomfort—Thalidomide—leprosy	0.00124	0.00538	CcSEcCtD
Dorzolamide—CA2—skin of body—leprosy	0.00124	0.0235	CbGeAlD
Dorzolamide—Dry mouth—Thalidomide—leprosy	0.00123	0.00532	CcSEcCtD
Dorzolamide—Confusional state—Thalidomide—leprosy	0.00122	0.00526	CcSEcCtD
Dorzolamide—Oedema—Thalidomide—leprosy	0.00121	0.00522	CcSEcCtD
Dorzolamide—Shock—Thalidomide—leprosy	0.00119	0.00513	CcSEcCtD
Dorzolamide—CA1—nervous system—leprosy	0.00118	0.0225	CbGeAlD
Dorzolamide—Hyperhidrosis—Thalidomide—leprosy	0.00117	0.00504	CcSEcCtD
Dorzolamide—Anorexia—Thalidomide—leprosy	0.00115	0.00497	CcSEcCtD
Dorzolamide—CA4—tendon—leprosy	0.00114	0.0216	CbGeAlD
Dorzolamide—Hypotension—Thalidomide—leprosy	0.00113	0.00488	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Thalidomide—leprosy	0.0011	0.00475	CcSEcCtD
Dorzolamide—Insomnia—Thalidomide—leprosy	0.00109	0.00472	CcSEcCtD
Dorzolamide—Paraesthesia—Thalidomide—leprosy	0.00108	0.00468	CcSEcCtD
Dorzolamide—Dyspnoea—Thalidomide—leprosy	0.00108	0.00465	CcSEcCtD
Dorzolamide—Somnolence—Thalidomide—leprosy	0.00107	0.00464	CcSEcCtD
Dorzolamide—Dyspepsia—Thalidomide—leprosy	0.00106	0.00459	CcSEcCtD
Dorzolamide—Decreased appetite—Thalidomide—leprosy	0.00105	0.00454	CcSEcCtD
Dorzolamide—Fatigue—Thalidomide—leprosy	0.00104	0.0045	CcSEcCtD
Dorzolamide—Pain—Thalidomide—leprosy	0.00103	0.00446	CcSEcCtD
Dorzolamide—Feeling abnormal—Thalidomide—leprosy	0.000995	0.0043	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Thalidomide—leprosy	0.000988	0.00427	CcSEcCtD
Dorzolamide—Urticaria—Thalidomide—leprosy	0.000959	0.00414	CcSEcCtD
Dorzolamide—Body temperature increased—Thalidomide—leprosy	0.000955	0.00412	CcSEcCtD
Dorzolamide—Abdominal pain—Thalidomide—leprosy	0.000955	0.00412	CcSEcCtD
Dorzolamide—CA2—tendon—leprosy	0.000943	0.0179	CbGeAlD
Dorzolamide—CA4—testis—leprosy	0.000942	0.0179	CbGeAlD
Dorzolamide—CA4—nervous system—leprosy	0.000924	0.0176	CbGeAlD
Dorzolamide—Hypersensitivity—Thalidomide—leprosy	0.00089	0.00384	CcSEcCtD
Dorzolamide—Asthenia—Thalidomide—leprosy	0.000866	0.00374	CcSEcCtD
Dorzolamide—Pruritus—Thalidomide—leprosy	0.000854	0.00369	CcSEcCtD
Dorzolamide—Diarrhoea—Thalidomide—leprosy	0.000826	0.00357	CcSEcCtD
Dorzolamide—Dizziness—Thalidomide—leprosy	0.000799	0.00345	CcSEcCtD
Dorzolamide—CA2—testis—leprosy	0.000781	0.0148	CbGeAlD
Dorzolamide—Vomiting—Thalidomide—leprosy	0.000768	0.00332	CcSEcCtD
Dorzolamide—CA2—nervous system—leprosy	0.000766	0.0146	CbGeAlD
Dorzolamide—Rash—Thalidomide—leprosy	0.000761	0.00329	CcSEcCtD
Dorzolamide—Dermatitis—Thalidomide—leprosy	0.000761	0.00329	CcSEcCtD
Dorzolamide—Headache—Thalidomide—leprosy	0.000757	0.00327	CcSEcCtD
Dorzolamide—Nausea—Thalidomide—leprosy	0.000717	0.0031	CcSEcCtD
Dorzolamide—CYP3A4—nervous system—leprosy	0.000494	0.0094	CbGeAlD
